Cargando…

Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells

BACKGROUND: This study investigates the docetaxel-resistant mechanism and explores the effect of tea polyphenols (TP) on autophagy and its related mechanism in human castration-resistant prostate cancer (CRPC) cell lines PC3 and DU145. METHODS: Immunofluorescence assay and annexin V-FITC/PI double s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Quan, He, Wei-Yang, Zeng, Yi-Zhou, Hossain, Arman, Gou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878207/
https://www.ncbi.nlm.nih.gov/pubmed/29460131
http://dx.doi.org/10.1007/s11255-018-1801-5
_version_ 1783310819971301376
author Wang, Quan
He, Wei-Yang
Zeng, Yi-Zhou
Hossain, Arman
Gou, Xin
author_facet Wang, Quan
He, Wei-Yang
Zeng, Yi-Zhou
Hossain, Arman
Gou, Xin
author_sort Wang, Quan
collection PubMed
description BACKGROUND: This study investigates the docetaxel-resistant mechanism and explores the effect of tea polyphenols (TP) on autophagy and its related mechanism in human castration-resistant prostate cancer (CRPC) cell lines PC3 and DU145. METHODS: Immunofluorescence assay and annexin V-FITC/PI double staining flow cytometry were used to analyze the apoptosis and autophagy of PC3 and DU145 cells. The expression of autophagy-related proteins was detected by western bolt. RESULTS: Docetaxel could induce autophagy and apoptosis, together with the expression increase in p-JNK, p-Bcl-2 and Beclin1. The level of autophagy was remarkably decreased, but apoptosis was increased after combining with TP. In addition, the expression of p-mTOR was increased after combining with TP. CONCLUSION: Docetaxel induces protective autophagy in CRPC cells by JNK pathway activation and then Bcl-2 phosphorylation and Beclin1 dissociation. TP activates mTOR pathway, which ultimately inhibits docetaxel-induced autophagy and improves therapeutic efficacy of docetaxel in CRPC cells.
format Online
Article
Text
id pubmed-5878207
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-58782072018-04-03 Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells Wang, Quan He, Wei-Yang Zeng, Yi-Zhou Hossain, Arman Gou, Xin Int Urol Nephrol Urology - Original Paper BACKGROUND: This study investigates the docetaxel-resistant mechanism and explores the effect of tea polyphenols (TP) on autophagy and its related mechanism in human castration-resistant prostate cancer (CRPC) cell lines PC3 and DU145. METHODS: Immunofluorescence assay and annexin V-FITC/PI double staining flow cytometry were used to analyze the apoptosis and autophagy of PC3 and DU145 cells. The expression of autophagy-related proteins was detected by western bolt. RESULTS: Docetaxel could induce autophagy and apoptosis, together with the expression increase in p-JNK, p-Bcl-2 and Beclin1. The level of autophagy was remarkably decreased, but apoptosis was increased after combining with TP. In addition, the expression of p-mTOR was increased after combining with TP. CONCLUSION: Docetaxel induces protective autophagy in CRPC cells by JNK pathway activation and then Bcl-2 phosphorylation and Beclin1 dissociation. TP activates mTOR pathway, which ultimately inhibits docetaxel-induced autophagy and improves therapeutic efficacy of docetaxel in CRPC cells. Springer Netherlands 2018-02-19 2018 /pmc/articles/PMC5878207/ /pubmed/29460131 http://dx.doi.org/10.1007/s11255-018-1801-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Urology - Original Paper
Wang, Quan
He, Wei-Yang
Zeng, Yi-Zhou
Hossain, Arman
Gou, Xin
Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title_full Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title_fullStr Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title_full_unstemmed Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title_short Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
title_sort inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
topic Urology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878207/
https://www.ncbi.nlm.nih.gov/pubmed/29460131
http://dx.doi.org/10.1007/s11255-018-1801-5
work_keys_str_mv AT wangquan inhibitingautophagyovercomesdocetaxelresistanceincastrationresistantprostatecancercells
AT heweiyang inhibitingautophagyovercomesdocetaxelresistanceincastrationresistantprostatecancercells
AT zengyizhou inhibitingautophagyovercomesdocetaxelresistanceincastrationresistantprostatecancercells
AT hossainarman inhibitingautophagyovercomesdocetaxelresistanceincastrationresistantprostatecancercells
AT gouxin inhibitingautophagyovercomesdocetaxelresistanceincastrationresistantprostatecancercells